UBS Group’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22	Closed	-$2	–	8938
2024 Q2	$2	Hold	22	–	–	﹤0.01%	8262
2024 Q1	$3	Buy	+22	New	+$3	﹤0.01%	7998
2023 Q4	–	Sell	-5,067	Closed	-$1.17K	–	8713
2023 Q3	$1.17K	Buy	+5,067	New	+$1.17K	﹤0.01%	6921